CONMED Corporation Announces Annual Meeting of Stockholders
March 22 2023 - 4:05PM
Business Wire
CONMED Corporation (NYSE: CNMD) today announced that its
Annual Meeting of Stockholders will be held on Wednesday, May 24,
2023, at 1:30 p.m. ET at its corporate headquarters at 11311
Concept Boulevard, Largo FL and through the internet virtually.
Shareholders of record at the close of business on March 28, 2023
shall be entitled to vote at the 2023 Annual Meeting.
Information about the meeting webcast and instructions for how
stockholders can attend or otherwise participate in the Annual
Meeting will be included in the definitive proxy statement expected
to be filed with the Securities and Exchange Commission on April
11, 2023 and available on the “Investors” section of CONMED’s web
site at www.conmed.com on that date.
About CONMED Corporation
CONMED is a medical technology company that provides surgical
devices and equipment for minimally invasive procedures. The
Company’s products are used by surgeons and physicians in a variety
of specialties, including orthopedics, general surgery, gynecology,
thoracic surgery, and gastroenterology. For more information, visit
www.conmed.com.
Forward-Looking Statements
This press release may contain forward-looking statements based
on certain assumptions and contingencies that involve risks and
uncertainties, which could cause actual results, performance, or
trends to differ materially from those expressed in the
forward-looking statements herein or in previous disclosures. For
example, in addition to general industry and economic conditions,
factors that could cause actual results to differ materially from
those in the forward-looking statements may include, but are not
limited to, the risks posed to the Company’s business, financial
condition, and results of operations by the COVID-19 global
pandemic and the various government and other responses to the
pandemic, including deferral of surgeries, reductions in hospital
and ambulatory surgery center operating volumes, disruption to
potential supply chain reliability, as well as the risk factors
discussed in the Company's Annual Report on Form 10-K for the full
year ended December 31, 2022 and listed under the heading
Forward-Looking Statements in the Company’s most recently filed
Form 10-Q. Any and all forward-looking statements are made pursuant
to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995 and relate to the Company’s performance on a
going-forward basis. The Company believes that all forward-looking
statements made by it have a reasonable basis, but there can be no
assurance that management’s expectations, beliefs or projections as
expressed in the forward-looking statements will actually occur or
prove to be correct.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230322005594/en/
CONMED Corporation Todd W. Garner Chief
Financial Officer 727-214-2975
ToddGarner@conmed.com
CONMED (NYSE:CNMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
CONMED (NYSE:CNMD)
Historical Stock Chart
From Jul 2023 to Jul 2024